233 related articles for article (PubMed ID: 25475375)
1. Evaluation of osseous metastasis in bone scintigraphy.
Davila D; Antoniou A; Chaudhry MA
Semin Nucl Med; 2015 Jan; 45(1):3-15. PubMed ID: 25475375
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].
Bathmann J; Moser E
Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445
[TBL] [Abstract][Full Text] [Related]
3. Bone scintigraphy in the evaluation of cancer.
Gupta V
Kathmandu Univ Med J (KUMJ); 2005; 3(3):243-8. PubMed ID: 18650585
[TBL] [Abstract][Full Text] [Related]
4. Osseous metastases of gastro-enteropancreatic neuroendocrine tumours. Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy.
Sabet A; Ezziddin S; Heinemann F; Guhlke S; Muckle M; Willinek W; Biersack HJ; Ahmadzadehfar H
Nuklearmedizin; 2012; 51(3):95-100. PubMed ID: 22421930
[TBL] [Abstract][Full Text] [Related]
5. Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma.
Tiwari BP; Jangra S; Nair N; Tongaonkar HB; Basu S
Indian J Cancer; 2010; 47(4):385-90. PubMed ID: 21131750
[TBL] [Abstract][Full Text] [Related]
6. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer.
Prior JO; Barghouth G; Delaloye JF; Leyvraz S; Bischof Delaloye A
Nucl Med Commun; 2003 Jan; 24(1):29-36. PubMed ID: 12501017
[TBL] [Abstract][Full Text] [Related]
7. [Bone scintigraphy in metastatic bone disease].
Itoh K
Kaku Igaku; 2000 Jan; 37(1):1-5. PubMed ID: 10714061
[TBL] [Abstract][Full Text] [Related]
8. [6. Quantitative Evaluation of the Bone Scintigraphy in the Prostate Cancer].
Yamamoto Y
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(10):1087-1094. PubMed ID: 29057782
[No Abstract] [Full Text] [Related]
9. [Clinical value of radionuclide whole body bone imaging in the diagnosis of skeletal metastasis].
Chen YQ
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):193-5. PubMed ID: 2612331
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
Koizumi M; Motegi K; Koyama M; Terauchi T; Yuasa T; Yonese J
Ann Nucl Med; 2017 Aug; 31(7):521-528. PubMed ID: 28456877
[TBL] [Abstract][Full Text] [Related]
11. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a computer-assisted diagnosis system, BONENAVI version 2, for bone scintigraphy in cancer patients in a routine clinical setting.
Koizumi M; Wagatsuma K; Miyaji N; Murata T; Miwa K; Takiguchi T; Makino T; Koyama M
Ann Nucl Med; 2015 Feb; 29(2):138-48. PubMed ID: 25326907
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of bone scintigraphy for early detection of bone metastasis from breast cancer].
Wada T; Hohjoh T; Matunami N; Yamato M; Kadota K; Morikawa E; Hara S; Matsuda T; Yasutomi M
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):781-5. PubMed ID: 2778373
[TBL] [Abstract][Full Text] [Related]
15. [Bone metastases in breast cancer and its risk factor--follow up study by bone scintigraphy].
Tanaka S; Matsumura Y; Tanaka M; Okamura T; Oda J; Ochi H; Onoyama Y; Morimoto K; Nakatani M; Fujimoto M
Kaku Igaku; 1991 Oct; 28(10):1177-80. PubMed ID: 1800779
[TBL] [Abstract][Full Text] [Related]
16. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
Koizumi M; Motegi K; Koyama M; Ishiyama M; Togawa T; Makino T; Arisaka Y; Terauchi T
Ann Nucl Med; 2020 Mar; 34(3):200-211. PubMed ID: 31970706
[TBL] [Abstract][Full Text] [Related]
18. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
[TBL] [Abstract][Full Text] [Related]
19. Solitary Thumb Acrometastasis Identified on Bone Scintigraphy.
Xie P; Huang J
Clin Nucl Med; 2017 Jul; 42(7):549-550. PubMed ID: 28240671
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of bone imaging in detecting the osseous metastasis of prostatic carcinoma].
Miki M
Rinsho Hoshasen; 1983 May; 28(5):585-7. PubMed ID: 6887614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
